XTL Biopharmaceuticals 8-K Shows Co.’s Investment, Intercure, Recently Purchased Canndoc Which Puts It In The Cannabis Space; BZ NOTE: Co. Only Holds 2.5% Stake In Intercure

https://www.sec.gov/Archives/edgar/data/1023549/000121390018015138/f6k110818ex99-1_xtlbio.htm


Image
igniteit
November 8, 2018
Share: